Viewing Study NCT05010005


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-08 @ 5:52 PM
Study NCT ID: NCT05010005
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2021-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module